Yiling Pharmaceutical Inc. announced that it will receive $7,250,000 in a round of equity funding from existing investor Shijiazhuang Yiling Pharmaceutical Co., Ltd. on March 17, 2015. Post the closing of the transaction, the registered capital of the company will increase to $8,300,000.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
18.53 CNY | -1.33% | -4.53% | -19.68% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-19.68% | 4.27B | |
+37.65% | 6.04B | |
+4.49% | 3.28B | |
-15.69% | 2.96B | |
-5.64% | 2.43B | |
+44.89% | 1.93B | |
-12.71% | 1.59B | |
-4.27% | 1.58B | |
-14.86% | 1.5B | |
+42.40% | 1.47B |
- Stock Market
- Equities
- 002603 Stock
- News Shijiazhuang Yiling Pharmaceutical Co., Ltd.
- Yiling Pharmaceutical Inc. announced that it expects to receive $7.25 million in funding from Shijiazhuang Yiling Pharmaceutical Co., Ltd..